Endeavor BioMedicines
PrivateLast Round
Series C
Apr 24, 2024
Total Funding Raised
$295.5M
Company Overview
Endeavor BioMedicines is a biotechnology company that develops precision medicines targeting the underlying genetic and cellular causes of life-threatening diseases such as pulmonary fibrosis and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endeavor BioMedicines Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Endeavor BioMedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 24, 2024 | ||||
| Series B | Feb 7, 2022 | ||||
| Series A | Jan 7, 2021 |
Key People
Founding team and executive leadership
Endeavor BioMedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C, Series B, Series A |
| Aberdeen Group plc | Series C |
| SymBiosis Capital Management | Series C |
| Omega Funds | Series C, Series B, Series A |
| Eckuity | Series C |
| Perceptive Advisors | Series C, Series B |
| abrdn Inc. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Two posters accepted for American Thoracic Society 2025 International Conference.
- Apr 2, 2025
Lisa Lancaster, M.D. appointed as new Chief Medical Officer.
Endeavor BioMedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Endeavor BioMedicines's valuation, stock price, and market status.